Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 15 results found. Search for [ Avigan trial ]

Results 1 to 15 of 15
Reuters
July 21, 2020
\"Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,\" the company said in a statement to the exchanges


PTI
July 11, 2020
The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by the expert committee


BusinessToday.In
July 10, 2020
Coronavirus vaccine news update: Serum Institute of India that is producing around four vaccine candidates including the Oxford University-AstraZeneca coronavirus candidate has said that it is expected to launch a candidate by the end of six months


Reuters
July 10, 2020
Known generically as favipiravir, Avigan was developed by a subsidiary of Fujifilm and it was approved in Japan as an emergency influenza treatment in 2014


E Kumar Sharma
July 1, 2020
Avigan, an antiviral drug to fight influenza, is believed to be effective in treatment of COVID-19 patients


PB Jayakumar
June 22, 2020
Pharma major is hopeful of exporting Fabiflu after the study proves efficacy of the drug in coronavirus treatment


PB Jayakumar
New Delhi, June 20, 2020
Glenmark developed active pharmaceutical ingredient and formulation for FabiFlu through in-house R&D; DCGI allowed fasttrack trials with Phase III in limited patients; approval process is also under Emergency Use Authorisation


Reuters
June 19, 2020
Glenmark said the approval was part of India's accelerated approval process and the drug was meant for 'restricted emergency use,' meaning patients must sign their consent before being treated by the drug


BusinessToday.In
New Delhi, June 1, 2020
Coronavirus vaccine news: In China, more than 2,000 people have been administered coronavirus vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products


BusinessToday.In
New Delhi, May 26, 2020
Coronavirus update: Japanese biopharmaceutical company AnGes Inc is set to begin the trial of its coronavirus vaccine in July, instead of September as estimated earlier


Reuters
May 26, 2020
Drugmakers across the world have been rushing to develop a treatment or vaccine for the fast-spreading coronavirus, which has infected 5.5 million people globally, killing more than 345,000


Reuters
May 26, 2020
Kyodo News late on Monday reported the government had given up on Avigan's May timeline


BusinessToday.In
May 21, 2020
Coronavirus lockdown 4.0 India highlights: Delhi reported the highest single-day spike of 571 fresh cases on Thursday, taking tally in the city to 11,659 and the death toll from coronavirus infection rose to 194


BusinessToday.In
New Delhi, May 13, 2020
Coronavirus vaccine: China's CanSino Biologics is working with Canada's National Research Council to find a vaccine while Japan expects to start clinical trials of COVID vaccine in July


Reuters
April 30, 2020
Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT


PAGES 1 OF 1